Acinar development of breast

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

Among controls, women in the highest tertile of serum taurine had 60% lower odds of developing hypertension compared to those in the lowest tertile (OR 0.40, 95% CI 0.17-0.97, p for trend = 0.04). In

Effect: improvement; OR 0.40; CI: 95% CI 0.17-0.97

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null

There was a non-significant inverse association between serum taurine and risk of diabetes. Women who developed diabetes had lower mean serum taurine (118.5 nmol/ml) compared with those who did not (1

Effect: null